Rocket Pharmaceuticals (RCKT) Other Operating Expenses (2017 - 2020)

Rocket Pharmaceuticals (RCKT) reported Other Operating Expenses of -$1000.0 for Q4 2020, down 200.0% sequentially from $1000.0 in Q4 2018.

Rocket Pharmaceuticals (RCKT) Other Operating Expenses (2017 - 2020) Analysis & Trends

Rocket Pharmaceuticals (RCKT) has 3 years of Other Operating Expenses data on file, last reported at -$1000.0 in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Rocket Pharmaceuticals 357.93 Mn 357.93 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2020 -1,000.00
Dec 31, 2018 1,000.00
Sep 30, 2018 -39,000.00
Jun 30, 2018 -5,000.00
Mar 31, 2018 15,000.00
Dec 31, 2017 1,000.00